[{"_id":"5641e952fd1ef1594b89cb2e","決算期":"2014年3月期","証券コード":"4534","会社名":"持田製薬(株)【4534】","会計方式":"日本方式","決算発表日":"2014年5月12日","決算月数":"12か月","売上高":"93,947百万円","営業利益":"16,600百万円","経常利益":"16,799百万円","当期利益":"9,892百万円","EPS（一株当たり利益）":"488.66円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"4,665.16円","総資産":"130,669百万円","自己資本":"93,688百万円","資本金":"7,229百万円","有利子負債":"875百万円","自己資本比率":"71.7%","ROA（総資産利益率）":"7.87%","ROE（自己資本利益率）":"10.86%","総資産経常利益率":"13.36%","日付":"2015-11-10T12:55:46.123Z"},{"_id":"5641e952fd1ef1594b89cb34","決算期":"2015年3月期","証券コード":"4534","会社名":"持田製薬(株)【4534】","会計方式":"日本方式","決算発表日":"2015年5月15日","決算月数":"12か月","売上高":"87,252百万円","営業利益":"11,689百万円","経常利益":"11,909百万円","当期利益":"7,544百万円","EPS（一株当たり利益）":"377.27円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"4,968.40円","総資産":"127,557百万円","自己資本":"98,670百万円","資本金":"7,229百万円","有利子負債":"500百万円","自己資本比率":"77.4%","ROA（総資産利益率）":"5.84%","ROE（自己資本利益率）":"7.84%","総資産経常利益率":"9.22%","日付":"2015-11-10T12:55:46.123Z"},{"_id":"5641e952fd1ef1594b89cb3d","決算期":"2013年3月期","証券コード":"4534","会社名":"持田製薬(株)【4534】","会計方式":"日本方式","決算発表日":"2013年5月13日","決算月数":"12か月","売上高":"89,210百万円","営業利益":"14,017百万円","経常利益":"14,188百万円","当期利益":"9,152百万円","EPS（一株当たり利益）":"88.45円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"861.47円","総資産":"120,828百万円","自己資本":"88,542百万円","資本金":"7,229百万円","有利子負債":"875百万円","自己資本比率":"73.3%","ROA（総資産利益率）":"7.83%","ROE（自己資本利益率）":"10.72%","総資産経常利益率":"12.14%","日付":"2015-11-10T12:55:46.123Z"}]